BCLI BRAINSTORM CELL THERAPEUTICS INC Capital Structure Changes 8-K Filing 2025 - Warrant Agreement On March 31, 2025, Brainstorm Cell Therapeutics entered into an agreement to induce the exercise of existing warrants for up to 1,381,383 shares, expecting to raise approximately $1.64 million for working capital. The new warrants will have an exercise price of $1.19 per share and will require stockholder approval before they can be exercised.Get access to all SEC 8-K filings of the BRAINSTORM CELL THERAPEUTICS INC